Showing 1 - 20 results of 32,961 for search '(( 50 mg decrease ) OR ( 5 ((((mm decrease) OR (nn decrease))) OR (we decrease)) ))', query time: 0.55s Refine Results
  1. 1
  2. 2

    Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50. by Khamis Mustafa (17941332)

    Published 2024
    “…<p>Cell lysates were obtained from THP-1 monocytes exposed to reagents as indicated: Lane 1, vehicle; Lane 2, PARP inhibitor olaparib (5 mM, 24 hr); Lane 3, oxLDL (100 mg/mL, 24 hr) or Lane 4, combination of oxLDL and olaparib. …”
  3. 3
  4. 4
  5. 5

    Trial profile. by Chanel Avenant (409756)

    Published 2024
    Subjects:
  6. 6
  7. 7

    Data_Sheet_5_Chemical Similarity of Co-occurring Trees Decreases With Precipitation and Temperature in North American Forests.CSV by Brian E. Sedio (10875330)

    Published 2021
    “…To test this prediction, we compared patterns of chemical and morphological trait diversity of 140 woody plant species among seven temperate forests in North America representing 16.2°C variation in mean annual temperature (MAT), 2,115 mm variation in mean annual precipitation (MAP), and from 10 to 68 co-occurring species. …”
  8. 8
  9. 9
  10. 10

    Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

    Published 2025
    “…<b>(B)</b> A significant decrease in the proliferative clonal capacity of U251MG colonies was observed with 50ΜM and 100ΜM SHG-44 treatment. …”
  11. 11
  12. 12

    Fig 3 - by Nida Mansoora (11648641)

    Published 2021
    Subjects:
  13. 13

    Fig 4 - by Nida Mansoora (11648641)

    Published 2021
    Subjects:
  14. 14

    Fig 1 - by Nida Mansoora (11648641)

    Published 2021
    Subjects:
  15. 15

    Fig 2 - by Nida Mansoora (11648641)

    Published 2021
    Subjects:
  16. 16

    Fig 5 - by Matthew C. Kochem (18476069)

    Published 2024
    Subjects:
  17. 17

    FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma. by Laura L. Stafman (6577184)

    Published 2019
    “…When tumors reached an average of 150 mm<sup>3</sup>, mice were randomized to receive vehicle (ORA-Plus, 50 μL, n = 7) or FTY720 (10 mg/kg body weight/day in ORA-Plus, 50 μL, n = 7) by oral gavage for 16 days. …”
  18. 18
  19. 19
  20. 20